Info@ThinkPinkRocks.org

Antares Pharma, Inc. today announced that the New Drug Application for OTREXUP, a potential new product for the subcutaneous delivery of methotrexate using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.

See the original article here:
FDA accepts Antares Pharma’s New Drug Application for OTREXUP

Scroll to Top